News

Filter

Current filters:

Uroxatral

1 to 9 of 10 results

Sanofi-Aventis buys US market rights to AEterna Zentaris' cetrorelix for up to $165M

16-03-2009

AEterna Zentaris, a Canadian biopharmaceutical firm focused on endocrine therapy and oncology, has signed…

Alfuzosin HClAventis PharmaCetrorelixCetrotideCialisEligardLeuprolide AcetateLillySanofi-AventisTadalafilUroxatral

Alfuzosin fails to improve prostatitis

12-01-2009

French drug major Sanofi-Aventis' Uroxatral (alfuzosin) failed to significantly reduce symptoms in recently-diagnosed…

Alfuzosin HClAventis PharmaSanofi-AventisUroxatral

Sanofi-Aventis' Uroxatral improves symptoms of BPH

06-06-2005

French drug major Sanofi-Aventis has released interim results from its ongoing, open-label study demonstrating…

Alfuzosin HClAventis PharmaSanofi-AventisUroxatral

Sanofi's Uroxatral available in the USA

10-11-2003

Sanofi-Synthelabo has launched Uroxatral (alfuzosin hydrochlorideextended-release tablets) in the USA.…

Alfuzosin HClAlphaProlastinUroxatral

France's Sanofi-Synthelabo announces New York stock listing

08-07-2002

Leading French drugmaker Sanofi-Synthelabo has listed on the New YorkStock Exchange, with trading commencing…

Alfuzosin HClAmbienArixtraAvaproClopidogrelElitekfondaparinuxirbesartanOrganonPharmaciaPlavixRasburicaseUroxatralZolpidem Tartrate

UroXatral approvable, says US FDA

12-10-2001

UK-based SkyePharma and French partner Sanofi-Synthelabo have receivedan approvable letter from the US…

Alfuzosin HClNystatinOralUroxatral

Lorex's Xatral SR

27-11-1995

- Synthelabo subsidiary Lorex has launched a sustained-release formulation of alfuzosin HCl, called Xatral…

Alfuzosin HClUroxatral

1 to 9 of 10 results

Back to top